Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

BNGO

Bionano Genomics (BNGO)

Bionano Genomics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BNGO
DateTimeSourceHeadlineSymbolCompany
14/09/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
14/09/202406:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
09/09/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNGOBionano Genomics Inc
04/09/202422:00GlobeNewswire Inc.Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment ConferenceNASDAQ:BNGOBionano Genomics Inc
22/08/202407:00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BNGOBionano Genomics Inc
22/08/202406:59Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BNGOBionano Genomics Inc
13/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BNGOBionano Genomics Inc
13/08/202407:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BNGOBionano Genomics Inc
08/08/202406:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNGOBionano Genomics Inc
08/08/202406:01GlobeNewswire Inc.Bionano Reports Second Quarter 2024 Results and Highlights Recent Business ProgressNASDAQ:BNGOBionano Genomics Inc
01/08/202422:00GlobeNewswire Inc.Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual MeetingNASDAQ:BNGOBionano Genomics Inc
01/08/202406:21Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNGOBionano Genomics Inc
01/08/202406:01GlobeNewswire Inc.Bionano to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:BNGOBionano Genomics Inc
31/07/202422:00GlobeNewswire Inc.Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024NASDAQ:BNGOBionano Genomics Inc
23/07/202422:00GlobeNewswire Inc.Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple MyelomaNASDAQ:BNGOBionano Genomics Inc
19/07/202406:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNGOBionano Genomics Inc
11/07/202405:54Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BNGOBionano Genomics Inc
09/07/202407:25GlobeNewswire Inc.Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:BNGOBionano Genomics Inc
08/07/202420:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BNGOBionano Genomics Inc
08/07/202420:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BNGOBionano Genomics Inc
05/07/202422:00GlobeNewswire Inc.Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:BNGOBionano Genomics Inc
02/07/202422:00GlobeNewswire Inc.Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual MeetingNASDAQ:BNGOBionano Genomics Inc
20/06/202422:00GlobeNewswire Inc.Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing ResearchNASDAQ:BNGOBionano Genomics Inc
18/06/202406:05GlobeNewswire Inc.Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy AnalysisNASDAQ:BNGOBionano Genomics Inc
11/06/202407:12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BNGOBionano Genomics Inc
06/06/202407:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
06/06/202407:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
06/06/202407:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
06/06/202407:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
06/06/202407:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BNGOBionano Genomics Inc
 Showing the most relevant articles for your search:NASDAQ:BNGO